BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ - Get Free Report) shares dropped 0.9% on Tuesday . The company traded as low as $2.24 and last traded at $2.30. Approximately 80,597 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 62,169,492 shares. The stock had previously closed at $2.32.
BioRestorative Therapies Trading Down 1.0 %
The company has a market cap of $3.90 billion, a PE ratio of -2.22 and a beta of 102.36. The stock has a fifty day simple moving average of $1.68 and a two-hundred day simple moving average of $1.63.
About BioRestorative Therapies
(
Get Free Report)
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company's two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
See Also
Before you consider BioRestorative Therapies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioRestorative Therapies wasn't on the list.
While BioRestorative Therapies currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
